Abstract:Abstract Nuclear receptors (NRs) are ligand-dependent transcription factors which are involved in the proliferation/development of normal and neoplastic cells. The family of NR genes consists of 48 elements and the endogenous ligands binding the majority of NRs are known. Indeed, it is generally assumed that NRs function as sensors for fat-soluble hormones, vitamins and dietary lipids. For instance, RARs (Retinoic Acid Receptors) bind to and are trans-activated by retinoic acids, the active metabolites of vitamin A, while ERs (Estrogen Receptors) and PR (Progesterone Receptor) interact with estradiol and progesterone, respectively. In spite of all the available information, there are at least 15 NRs (ONRs, Orphan Nuclear Receptors), which are still devoid of a recognized endogenous ligand. The dysregulation of NRs has been associated with different types of cancer. NRs act in hierarchical, integrated networks to promote tissue- and cell-specific functions. In breast cancer, the role of ERs and PR has been thoroughly investigated, while the function of other members of the NR family is largely unknown. In the present study, we define the expression levels of NR mRNAs in normal and breast cancer tissues, using public databases. The results obtained indicate that the majority of NRs are deregulated in mammary tumors. We focus our attention on ONRs, as many of them are differentially expressed in normal and tumor samples. To get functional information, we use the siRNA technology to assess the effects of ONR silencing on the growth/motility of breast cancer cells. To this purpose, we employ 40 cell lines, which are representative of the different tumor subtypes. We choose at least five cell lines among the ones with high, medium and low expression of the ONR under investigation. We transiently silence the selected NR with the transfection of at least 3 selective siRNAs. Cell proliferation is evaluated after 2, 4 and 6-days from the transfection of the siRNAs using the sulphorodamine assay. We identify NR2F6 as the only ONR whose silencing inhibits cell proliferation. In contrast, NR2F2 silencing increases cell proliferation. We confirm the results obtained on NR2F6 with the use of the CRISPR/CAS9 and the shRNA technologies. In line with our results, NR2F6 expression is higher, while NR2F2 expression is lower, in breast tumors than in normal tissue. Interestingly, the highest levels of NR2F6 protein are observed in ER- and in HER2-positive breast cancer cell-lines. By converse, Triple-Negative cells are endowed with the lowest levels of this ONR. To identify the gene-networks modulated by NR2F2 and NR2F6, we performed RNA-sequencing experiments in control and silenced breast cancer cells, which provide evidence on the underlying molecular mechanisms of action. In conclusion, our data indicate that NR2F2 and NR2F6 represent novel targets for the development of therapeutic strategies in the context of the personalized treatment of breast cancer. Citation Format: Gabriela Paroni, Maria Azzurra Caricasulo, Adriana Zanetti, Andrea Cavallaro, Luca Guarrera, Mineko Terao, Enrico Garattini. The role of orphan nuclear receptors in breast cancer cell proliferation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3074.

Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma.

Tumorigenesis and Neoplastic Progression Tumorigenic Role of Orphan Nuclear Receptor NR 0 B 1 in Lung Adenocarcinoma

Nkx2-1: a Novel Tumor Biomarker of Lung Cancer

Abstract 3074: The role of orphan nuclear receptors in breast cancer cell proliferation

NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors

NPM3 As a Novel Oncogenic Factor and Poor Prognostic Marker Contributes to Cell Proliferation and Migration in Lung Adenocarcinoma

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.

NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome

Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog

The orphan nuclear receptor NR0B2 could be a novel susceptibility locus associated with microsatellite‐stable, APC mutation‐negative early‐onset colorectal carcinomas with metabolic manifestation

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells

NR3C2 affects the proliferation and invasiveness of colon cancer cells through the Wnt/β-Catenin signaling pathway

Inhibition of NOB1 by Microrna-330-5p Overexpression Represses Cell Growth of Non-Small Cell Lung Cancer.

NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma

tsRNA-5001a promotes proliferation of lung adenocarcinoma cells and is associated with postoperative recurrence in lung adenocarcinoma patients

High NR2F2 Transcript Level is Associated with Increased Survival and Its Expression Inhibits TGF-β-dependent Epithelial-Mesenchymal Transition in Breast Cancer

Abstract 6531: Anti-tumor immune function of NR2F6, an orphan nuclear receptor, in stromal cells

Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer

Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas

Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy